Acne and itch: direct relationship or comorbidity?

References

• Bergfeld WF. The evaluation and management of acne: economic considerations. J. Am. Acad. Dermatol.32(5), S52–S56 (1995).
   Google Scholar
• Galobardes B, Davey Smith G, Jefferys M, McCarron P. The Glasgow Alumni Cohort. Has acne increased? Prevalence of acne history among university students between 1948 and 1968. The Glasgow Alumni Cohort Study. Br. J. Dermatol.152(4), 824–825 (2005).
   Google Scholar
• Reich A, Jasiuk B, Samotij D, Tracinska A, Trybucka K, Szepietowski JC. Acne vulgaris: what teenagers think about it. Dermatol. Nurs.19(1), 49–54, 64 (2007).
   PubMedGoogle Scholar
• Niemeier V, Kupfer J, Demmelbauer-Ebner M, Stangier U, Effendy I, Gieler U. Coping with acne vulgaris. Evaluation of the chronic skin disorder questionnaire in patients with acne. Dermatology196(1), 108–115 (1998).
   PubMed Web of Science ®Google Scholar
• Szepietowski JC, Reich A, Pacan P. Psychodermatoses in haemodialysis patients. Dermatology209(4), 344–345 (2004).
   Google Scholar
• Yosipovitch G, Greaves MW. Definitions of itch. In: Itch. Basic Mechanisms and Therapy. Yosipovitch G, Greaves MW, Fleischer AB Jr, McGlone F (Eds). Marcel Dekker Inc., NY, USA, 1–4 (2004).
   Google Scholar
• Melamed Y, Yosipovitch G. Itching as a focus of mental disturbance. In: Itch. Basic Mechanisms and Therapy. Yosipovitch G, Greaves MW, Fleischer AB Jr, McGlone F (Eds). Marcel Dekker Inc., NY, USA, 369–375 (2004).
   Google Scholar
• Fisher DA. A syndrome of acne vulgaris and subclinical demographic urticaria. Cutis47(6), 429–432 (1991).
   Google Scholar
• Levine MI. A syndrome of acne vulgaris and subclinical dermographism. Cutis,49(1), 25 (1992).
   Google Scholar
• Fleischer AB Jr. The Clinical Management of Itching. Parthenon Publishing, NY, USA, 145–157 (2000).
   Google Scholar
• Padilha-Goncalves A, Alvimar Ferreira J. Solar acne. Med. Cutan. Ibero Lat. Am.5(4), 271–274 (1977).
   Google Scholar
• Yee KC, Cunliffe WJ. Itching in acne – an unusual complication of therapy. Dermatology189(2), 117–119 (1994).
   Google Scholar
• Reich A, Trybucka K, Tracinska A et al. Acne itch: is it a real problem for patient with acne? Dermatol. Klin.9(Suppl. 1), 31 (2007).
   Google Scholar
• Reich A, Trybucka K, Tracinska A et al. Acne itch: do acne patients suffer from itching? Acta Derm. Venereol. (Stockh.) doi 10.2340/ 00015555-0355 (2007) (Epub ahead of print).
   Google Scholar
• McEvoy B, Nydegger R, Williams G. Factors related to patient compliance in the treatment of acne vulgaris. Int. J. Dermatol.42(4), 274–280 (2003).
   PubMed Web of Science ®Google Scholar
• Chen CF, Wu KG, Hsu MC, Tang RB. Prevalence and relationship between allergic diseases and infectious diseases. J. Microbiol. Immunol. Infect.34(1), 57–62 (2001).
   PubMedGoogle Scholar
• Farrell LN, Strauss JS, Stranieri AM. The treatment of severe cystic acne with 13-cis-retinoic acid. Evaluation of sebum production and the clinical response in a multiple-dose trial. J. Am. Acad. Dermatol.3(6), 602–611 (1980).
   PubMed Web of Science ®Google Scholar
• Korting HC, Braun-Falco O. Efficacy and tolerability of combined topical treatment of acne vulgaris with tretinoin and erythromycin in general practice. Drugs Exp. Clin. Res.15(9), 447–451 (1989).
   PubMedGoogle Scholar
• Domínguez J, Hojyo MT, Celayo JL, Domínguez-Soto L, Teixeira F. Topical isotretinoin vs. topical retinoic acid in the treatment of acne vulgaris. Int. J. Dermatol.37(1), 54–55 (1998).
   PubMedGoogle Scholar
• Shalita A, Weiss JS, Chalker DK et al. A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: a multicenter trial. J. Am. Acad. Dermatol.34(3), 482–485 (1996).
   PubMed Web of Science ®Google Scholar
• Caron D, Sorba V, Kerrouche N, Clucas A. Split-face comparison of adapalene 0.1% gel and tretinoin 0.025% gel in acne patients. J. Am. Acad. Dermatol.36(Suppl. 6), S110–S112 (1997).
   PubMed Web of Science ®Google Scholar
• Grosshans E, Marks R, Mascaro JM et al. Evaluation of clinical efficacy and safety of adapalene 0.1% gel versus tretinoin 0.025% gel in the treatment of acne vulgaris, with particular reference to the onset of action and impact on quality of life. Br. J. Dermatol.139(Suppl. 52), 26–33 (1998).
   Google Scholar
• Ellis CN, Millikan LE, Smith EB et al. Comparison of adapalene 0.1% solution and tretinoin 0.025% gel in the topical treatment of acne vulgaris. Br. J. Dermatol.139(Suppl. 52), 41–47 (1998).
   PubMed Web of Science ®Google Scholar
• Ioannides D, Rigopoulos D, Katsambas A. Topical adapalene gel 0.1% vs. isotretinoin gel 0.05% in the treatment of acne vulgaris: a randomized open-label clinical trial. Br. J. Dermatol.147(3), 523–527 (2002).
   PubMed Web of Science ®Google Scholar
• Leyden JJ, Tanghetti EA, Miller B, Ung M, Berson D, Lee J. Once-daily tazarotene 0.1 % gel versus once-daily tretinoin 0.1 % microsponge gel for the treatment of facial acne vulgaris: a double-blind randomized trial. Cutis69(Suppl. 2), 12–19 (2002).
   PubMedGoogle Scholar
• Thiboutot D, Gold MH, Jarratt MT et al. Randomized controlled trial of the tolerability, safety, and efficacy of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris. Cutis68(Suppl. 4), 10–19 (2001).
   PubMedGoogle Scholar
• Shalita AR, Berson DS, Thiboutot DM et al. Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials. Clin. Ther.26(11), 1865–1873 (2004).
   PubMed Web of Science ®Google Scholar
• Goulden V, Glass D, Cunliffe WJ. Safety of long-term high-dose minocycline in the treatment of acne. Br. J. Dermatol.134(4), 693–695 (1996).
   PubMed Web of Science ®Google Scholar
• Frampton JE, Wagstaff AJ. Azelaic acid 15% gel: in the treatment of papulopustular rosacea. Am. J. Clin. Dermatol.5(1), 57–64 (2004).
   PubMed Web of Science ®Google Scholar
• Szepietowski J, Reich A. Azelaic acid in gel base: application in acne vulgaris and rasacea. Dermatol. Klin.5(4), 223–226 (2003).
   Google Scholar
• Rasmussen JE, Smith SB. Patients concepts and misconceptions about acne. Arch. Dermatol.119(7), 570–572 (1983).
   Google Scholar
• Katsambas AD. Why and when the treatment of acne fails. Dermatology196(1), 158–161 (1998).
   PubMed Web of Science ®Google Scholar
• Brajac I, Bilić-Zulle L, Tkalčić M, Lončarek K, Gruber F. Acne vulgaris: myths and misconception among patients and family physician. Patient Educ. Couns.54(1), 21–25 (2004).
   Google Scholar
• Fuchs E, Lynfield Y. Dialysis acne. J. Am. Acad. Dermatol.23(1), 125 (1990).
   Google Scholar
• Marcusson JA, Tyden G. Acne conglobata in transplant patients treated with isotretinoin. Br. J. Dermatol.118(2), 310–312 (1988).
   Google Scholar
• Lin J, Shih I, Yu C. Hemodialysis-related nodulocystic acne treated with isotretinoin. Nephron81(2), 146–150 (1999).
   Google Scholar
• Grange F, Mitschler A, Genestier S, Guillaume JC. Severe acne with pruritus in dialysis patients with renal failure. The difficulties of diagnosis and efficacy of isotretinoin. Ann. Dermatol. Venereol.128(11), 1215–1219 (2001).
   Google Scholar
• Beightler EL, Tyring SK. The use of isotretinoin in patient undergoing kidney hemodialysis. J. Am. Acad. Dermatol.23(4), 758 (1990).
   Google Scholar
• Kent A, Drummond LM. Acne excoriée – a case report of treatment using habit reversal. Clin. Exp. Dermatol.14(2), 163–164 (1989).
   PubMed Web of Science ®Google Scholar
• Gupta MA, Gupta AK. Olanzapine may be an effective adjunctive therapy in the management of acne excoriee: a case report. J. Cutan. Med. Surg.5(1), 25–27 (2001).
   PubMedGoogle Scholar
• Ayers K, Sweeney SM, Wiss K. Pityrosporum folliculitis. Diagnosis and management in 6 female adolescents with acne vulgaris. Arch. Pediatr. Adolesc. Med.159, 64–67 (2005).
   PubMedGoogle Scholar
• Kortüm A-K, Meller S, Hengge U, Kruse R, Reifenberger J, Bruch-Gerharz D. Pityrosporum follikulitis (Malassezia follikulitis). Hautarzt57(10), 903–912 (2006).
   Google Scholar
• Borton LK, Schwartz RA. Pityrosporum folliculitis: a common acneiform condition of middle age. Ariz. Med.38, 598–601 (1981).
   Google Scholar
• Fearfield LA, Rowe A, Francis N, Bunker CB, Staughton RCD. Itchy folliculitis and human immunodeficiency virus infection: clinicopathological and immunological features, pathogenesis and treatment. Br. J. Dermatol.141(1), 3–11 (1999).
   Google Scholar
• Weary PE, Russell CM, Butler HK, Hsu YT. Acneiform eruption resulting from antibiotic administration. Arch. Dermatol.100, 179–183 (1969).
   PubMedGoogle Scholar
• Budavari JM, Grayson W. Papular follicular eruptions in human immunodeficiency virus-positive patients in South Africa. Int. J. Dermatol.46(7), 706–710 (2007).
   PubMed Web of Science ®Google Scholar
• Gupta AK, Batra R, Bluhm R, Boekhout T, Dawson TL Jr. Skin diseases associated with Malassezia species. J. Am. Acad. Dermatol.51(5), 785–798 (2004).
   PubMed Web of Science ®Google Scholar
• Bäck O, Faergemann J, Hörnqvist R. Pityrosporum folliculitis: a common disease of the young and middle-aged. J. Am. Acad. Dermatol.12, 56–61 (1985).
   PubMed Web of Science ®Google Scholar
• Wolff HH, Plewig G, Januschke E. Ultrastructure and microflora in follicles and comedones. Hautarzt27, 432–440 (1976).
   Google Scholar
• Yu H-Y, Lee S-K, Son SJ, Kim YS, Yang HY, Kim JH. Steroid acne vs. Pityrosporum folliculitis: the incidence of Pityrosporum ovale and the effect of antifungal drugs in steroid acne. Int. J. Dermatol.37(10), 772–777 (1998).
   PubMed Web of Science ®Google Scholar